SABBY Management, LLC, 10% Owner at Rosetta Genomics Ltd. (ROSG), bought 7,085 shares at $0.35 ($2K) on 2018-04-26, disclosed to the SEC on 2018-04-27.
Open-market purchase of $2k ROSG by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| VLCN | BUY | 2024-08-28 | $5K | — | Filing → |
| VLCN | BUY | 2024-08-26 | $11K | — | Filing → |
| VLCN | SELL | 2024-08-26 | $134K | — | Filing → |